Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy - Medical Xpress
Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy Medical Xpress
Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy Medical Xpress
After beating leukemia with support from his mentor, this teen stood by him through brain surgery Yahoo Lifestyle Canada
Naveen Pemmaraju: Final Day of Fellowship for 2 Outstanding Leukemia Fellows Oncodaily
How surviving leukemia changed Duke Health CEO's approach to patient care WRAL
College World Series Young leukemia survivor headed to Omaha to cheer on UNC in CWS finals ABC11 News
Oncology On The Go: Frontline Chronic Myeloid Leukemia in Chronic Phase: Optimizing Treatment Selection and Molecular Response CancerNetwork
Iowa boy with leukemia returns to baseball after parents create shirt to protect chemo port KCCI
UT MD Anderson Shares Latest Research Breakthroughs | Newswise Newswise
Chronic Myeloid Leukemia (CML): Background, Pathophysiology, Epidemiology Medscape eMedicine
Acute Myeloid Leukemia Therapeutics Market to Exceed USD 10.1 Billion by 2036 as Precision Oncology and Targeted Therapies Transform AML Treatment Landscape: Fact.MR 24-7 Press Release Newswire
Targeted efficacy of BCG Hsp70–anti-CD123 immunoconjugate in childhood acute myeloid leukemia Nature
Leukemia: What Primary Care Physicians Need to Know American Academy of Family Physicians | AAFP
2 healers, 1 lasting legacy: Mission of Akron Children's caregivers lives on through bone marrow donation WKYC
Ivosidenib Plus Azacitidine May Be Effective in IDH1 -Mutated AML Hematology Advisor
Richmond dad learned from AI his son had leukemia. Now the family’s helping others touched by childhood cancer Shaw Local
Enliven Therapeutics' leukemia drug shows promise in new study | STAT statnews.com
Acute Myeloid Leukemia (AML): Background, Pathophysiology, Etiology Medscape eMedicine
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets Nature
Inhibiting high levels of leukemia ABCD1 protein with jojoba could lead to new treatment option Medical Xpress
Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia Nature
Chronic B-cell Leukemias and Agent Orange VA Public Health (.gov)
Real-World Treatment Patterns With First-Line BTK Inhibitors in CLL OncLive
Fixed-Duration Triplet Therapy Demonstrates Efficacy for Patients with Relapsed/Refractory CLL Cancer Health
Sonrotoclax Plus Zanubrutinib Achieves Undetectable MRD Rates Above 90% in Frontline CLL/SLL Pharmacy Times
Dr Cuglievan on Results for Revumenib in Pediatric R/R KMT2A+ Acute Leukemia OncLive
Leading the Charge in Acute Myeloid Leukemia CU Anschutz newsroom
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D | Leukemia Nature
Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity Nature
Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’ UT MD Anderson
Iowa boy with leukemia returns to baseball after parents create shirt to protect chemo port Yahoo News Canada
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data Nature
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma | Leukemia Nature
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia Nature
WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy WVU Medicine
CRISPR-based platform pinpoints drivers of leukemia in patient cells Penn Medicine
The sialic shield of leukemia cells Science | AAAS
Leukemia Breakthroughs Are Helping Patients Live Longer City of Hope
Understanding acute myeloid leukemia Servier
Immunophenotypic changes following menin inhibition in acute myeloid leukemia Nature
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia The New England Journal of Medicine